Diagnosis

Candidiasis

A fungal infection caused by yeasts from the genus Candida.

Also known as: Candidosis, Moniliasis, Thrush

Etiology

Cause (>200 species exist) [s9k]

Pathophysiology [qaz][s9k]

  1. Yeast fungi is a part of the normal flora in the GI tract and vagina (13% of the women)

  2. Fungi causes disease in the immunocompromised and critical ill hospitalized patients

  3. Invasive candidiasis is a leading cause of mycosis-associated mortality

  4. Virulence factors:

    • Surface adherence molecules

    • Acid proteases and phospholipases that involve penetration and damage

    • Ability to convert to a hyphal form

Risk factors

Clinical presentations - oral cavity, vagina, penis, GI, respiratory, systemic

  1. Mucocutaneous: intertrigo, diaper dermatitis, erosio interdigitalis blastomycetica, perianal dermatitis, candidal balanitis, paronychia

  2. Oropharyngeal: oral thrush

  3. Esophageal: esophagitis

  4. Nonesophageal gastrointestinal

  5. Genitourinary tract: urinary tract infection, vulvovaginitis, balanitis

  6. Respiratory tract: laryngitis, tracheobronchitis, pneumonia

  7. Systemic: candidemia, endocarditis, myocarditis, pericarditis, endophthalmitis, renal candidiasis, CNS infections, arthritis

Epidemiology

Incidence per 100.000 [qaz][woq][fvp]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Balanitis, Cheilitis, Chills, Cough, Dyspareunia, Dysphagia, Dyspnea, Dysuria, Fever, Hematuria, Nausea, Odynophagia, Onychodystrophy, Onycholysis, Paronychia, Pruritus, Respiratory distress, Urinary urgency, Vaginal discharge, Vomiting, Vulvovaginitis

Clinical findings

Stomatitis

Anamneses

Antibiotics, Diabetes mellitus, HIV, Steroids

Localized findings

Pain
Radiates
Cavum oris (inside mouth)RetrosternalRegio epigastricaRegio hypogastrica
Onset
Subacute (hours)Gradual (days)
Pattern
Constant
Quality
Burning
Severity
Mild (1-3)Moderate (4-7)
Rash
Radiates
CaputThoraxAbdomenGenitalArmLower body
Distribution
AsymmetricGeneralizedIntertriginousLocalizedMultipleSymmetric
Lesion type
AtrophyErythemaFissurePapulePlaquePustuleUlcerVesicle
Color
RedWhite
Associated symptom
DischargeItch

Approach

Treatment

Guidelines by the Infectious Disease Society of America: [foc]

  1. Candidemia and invasive candiasis

    --> Echinocandins (Caspofungin, Micafungin, Anidulafungin)

    --> transition to fluconazole/amphotericin B if clinically stable

  2. Localized cutaneous candidiasis --> clotrimazole, econazole, ciclopirox, miconazole, ketoconazole, nystatin

  3. Extensive cutaneous infection or immunocompromised patients --> systemic antifungal therapy

  4. Candida onychomycosis --> oral itraconazole

  5. Paronychia --> fluconazole or itraconazole

  6. Oropharyngeal candidiasis --> topical antifungal agents (nystatin, clotrimazole, amphotericin B oral suspension) or systemic oral azoles (fluconazole, itraconazole, or posaconazole)

  7. Candida esophagitis --> systemic therapy with fluconazole

  8. Vulvovaginal candidiasis --> topical antifungal agents or oral fluconazole

  9. Candida cystitis --> fluconazole

  10. Renal candidiasis --> systemic fluconazole

  11. Chronic mucocutaneous candidiasis --> oral fluconazole

  12. Hepatosplenic candidiasis -->Induction with amphotericin B followed by fluconazole

  13. Respiratory tract candidiasis --> treated as disseminated candidiasis

  14. Surgery:

    • Abscess formation --> surgical drainage + antifungal therapy

    • Prosthetic infection --> removal of the prosthesis

    • Endocarditis --> Valve replacement surgery

    • Fungal endophthalmitis --> vitrectomy

Differential diagnoses

Abdominal abscess, Aspergillosis, Cryptococcosis, Eczema, Folliculitis, Impetigo, Intertrigo, Onychomycosis, Palmo+C790antar pustolosis, Psoriasis, Sepsis, Tinea


References

[1] R AN, Rafiq NB. Candidiasis. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560624/

[2] Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007 Jan;20(1):133-63.

[3] Nagao et al. Predictors of Candida spp. as causative agents of catheter-related bloodstream infections. Diagnostic Microbiology and Infectious Disease. 2014;80:200-203.

[4] Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014 Jan-Mar;31(1):42-8.

[5] Bassetti et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care 23, 219 (2019).

[6] http://emedicine.medscape.com/article/213853; [Medscape]

[7] http://emedicine.medscape.com/article/1090632; [Medscape]

[8] Xiao et al. Epidemiology, species distribution, antifungal susceptibility and mortality risk factors of candidemia among critically ill patients: a retrospective study from 2011 to 2017 in a teaching hospital in China. Antimicrob Resist Infect Control 8, 89 (2019).

[9] Alberto Cortés J, Fernanda Corrales I. Invasive Candidiasis: Epidemiology and Risk Factors. Fungal Infection. IntechOpen; 2019. Available from: http://dx.doi.org/10.5772/intechopen.81813

[10] Yapar, N. (2014). Epidemiology and risk factors for invasive candidiasis. Therapeutics and Clinical Risk Management, 10, 95–105.

[11] Pappas, P., Lionakis, M., Arendrup, M. et al. Invasive candidiasis. Nat Rev Dis Primers 4, 18026 (2018).

Scroll to top